Drug Targets in Kinetoplastid Parasites

1. Arsenite Resistance in Leishmania and Possible Drug Targets
Gaganmeet Singh, K. G. Jayanarayan, Chinmoy S. Dey

2. Unique Characteristics of the Kinetoplast DNA Replication Machinery Provide Potential Drug Targets in Trypanosomatids
Dotan Sela, Neta Milman, Irit Kapeller, Aviad Zick, Rachel Bezalel, Nurit Yaffe, Joseph Shlomai

3. Drugs and Transporters in Kinetoplastid Protozoa
Scott M.

4. Selective Lead Compounds against Kinetoplastid Tubulin
R.E. Morgan, K.A. Werbovetz*

5. Fishing for Anti-Leishmania Drugs: Principles and Problems
Emanuela Handman, Lukasz Kedzierski, Alessandro D. Uboldi, James W. Goding

6. Sterol 14-Demethylase Inhibitors for Trypanosoma cruzi Infections
Frederick S. Buckner

7. Histone Deacetylases
David Horn

8. Targeting Glycoproteins or Glycolipids and Their Metabolic Pathways for Antiparasite Therapy
Sumi Mukhopadhyay Bandyopadhyay, Chitra Mandal

9. DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy
Benu Brata Das, Agneyo Ganguly, Hemanta K. Majumder

10. Antiparasitic Chemotherapy:
Alok Kumar Datta, Rupak Datta, Banibrata Sen

11. Searching the Tritryp Genomes for Drug Targets
Peter J. Myler

12. Purine and Pyrimidine Metabolism in Leishmania
Nicola S. Carter, Phillip Yates, Cassandra S. Arendt, Jan M. Boitz, Buddy Ullman

DRM-restrictions

Printing: not available
Clipboard copying: not available

Avainsanat: TECHNOLOGY & ENGINEERING / Biomedical TEC059000